MSI Financial Services Inc - PROGENICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 107 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is 20.80 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
MSI Financial Services Inc ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2016$9,000
+50.0%
1,0000.0%0.00%–
Q3 2016$6,000
+50.0%
1,0000.0%0.00%–
Q2 2016$4,000–1,000–0.00%–
 Download
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q2 2016.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders